Einsatz neuer renaler Biomarker zur Früherkennung eines akuten Nierenversagens – contra

Literatur

• 1 Haase M, Bellomo R, Devarajan P. et al, for the NGAL Meta-analysis Investigator Group . Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury:.  Am J Kidney Dis. 2009;  54 1012-1024
  Google Scholar
• 2 Haase-Fielitz A, Bellomo R, Devarajan P. et al . The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury.  Nephrol Dial Transplant. 2009;  24 3349-3354
  Google Scholar
• 3 Mishra J, Ma Q, Prada A. et al . Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury.  J Am Soc Nephrol. 2003;  14 2534-2543
  Google Scholar
• 4 Nickolas T L, O’Rourke M J, Yang J. et al . Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury.  Ann intern Med. 2008;  148 810-819
  Google Scholar
• 5 Swets J A. Measuring the accuracy of diagnostic systems.  Science. 1988;  240 1285-1293
  Google Scholar

PD Dr. med. Michael Haase

Medizinische Klinik m. S. Nephrologie und internistische Intensivmedizin, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum

13353 Berlin

Email: michael.haase@charite.de